In last trading session, VolitionRX Ltd (AMEX:VNRX) saw 0.31 million shares changing hands with its beta currently measuring 1.15. Company’s recent per share price level of $0.69 trading at $0.03 or 5.44% at ring of the bell on the day assigns it a market valuation of $63.89M. That closing price of VNRX’s stock is at a discount of -78.26% from its 52-week high price of $1.23 and is indicating a premium of 37.68% from its 52-week low price of $0.43. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.13 million shares which gives us an average trading volume of 130.50K if we extend that period to 3-months.
VolitionRX Ltd (AMEX:VNRX) trade information
Upright in the green during last session for gaining 5.44%, in the last five days VNRX remained trading in the green while hitting it’s week-highest on Friday, 11/08/24 when the stock touched $0.69 price level, adding 8.61% to its value on the day. VolitionRX Ltd’s shares saw a change of -3.25% in year-to-date performance and have moved 14.76% in past 5-day. VolitionRX Ltd (AMEX:VNRX) showed a performance of -0.90% in past 30-days. Number of shares sold short was 0.4 million shares which calculate 3.33 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
VolitionRX Ltd (VNRX) estimates and forecasts
Statistics highlight that VolitionRX Ltd is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -16.32% of value to its shares in past 6 months, showing an annual growth rate of 36.00% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 174.80% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 650k for the same. And 5 analysts are in estimates of company making revenue of 1.01M in the next quarter. Company posted 165k and 244k of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 2.75% during past 5 years.
VolitionRX Ltd (AMEX:VNRX)’s Major holders
Insiders are in possession of 21.44% of company’s total shares while institution are holding 8.88 percent of that, with stock having share float percentage of 11.31%. Investors also watch the number of corporate investors in a company very closely, which is 8.88% institutions for VolitionRX Ltd that are currently holding shares of the company. LAGODA INVESTMENT MANAGEMENT, L.P. is the top institutional holder at VNRX for having 5.44 million shares of worth $3.29 million. And as of 2024-06-30, it was holding 6.6352 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 0.64 million shares on 2024-06-30. The number of shares represents firm’s hold over 0.7768 of outstanding shares, having a total worth of $0.39 million.
